Unknown

Dataset Information

0

Tailoring combinatorial cancer therapies to target the origins of adaptive resistance.


ABSTRACT: The development of resistance to chemotherapy is a critical yet poorly understood phenomenon driving cancer-related deaths. We recently reported a study that explored the origins of adaptive chemotherapy resistance. During this investigation we unexpectedly discovered that inherent vulnerabilities were unmasked, creating temporal targets for rational combinations of established drugs.

SUBMITTER: Goldman A 

PROVIDER: S-EPMC4845182 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC9555794 | biostudies-literature
| S-EPMC3720609 | biostudies-literature
| S-EPMC9992199 | biostudies-literature
| S-EPMC8574973 | biostudies-literature
| S-EPMC6118581 | biostudies-literature
| S-EPMC8037779 | biostudies-literature
| S-EPMC4780626 | biostudies-literature
| S-EPMC10912412 | biostudies-literature
| S-EPMC5704164 | biostudies-other
| S-EPMC7814417 | biostudies-literature